Anixa Biosciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

SAN JOSE, Calif.: SAN JOSE, Calif., Sept. 8, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today that Dr. Amit Kumar, Anixa's Chief Executive Officer, will present at the virtual H.C. Wainwright 23rd Annual Global...

Click to view original post